N. Dohmae
Molecular Biology · 2002–2020
A researcher in the Science corpus: 20 papers; trusts 21 researchers and is trusted by 8 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 171 citations into it; #4,995 of 17,773 by trust here, #4,000 by citations
- Surgery — 10 citations into it
Whom N. Dohmae trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts N. Dohmae overall
Papers from N. Dohmae's perspective
Ordered by how strongly the researchers N. Dohmae trusts endorse each paper. Same corpus, a different order for every researcher.
- SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
- Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. (Cell)
- Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers
- p53 is regulated by the lysine demethylase LSD1 (Nature)
- A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′ flanking region of SMYD3 is a risk factor for human cancers
- PCNA, the maestro of the replication fork. (Cell)
- RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO (Nature)
- Polycomb silencers control cell fate, development and cancer (Nature Reviews. Cancer)
- Epigenetic modifications and human disease (Nature Biotechnology)
- Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers
Their papers
- Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. (2004) — 1,131 citations
- Abstract 3019: Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells (2011) — 207 citations
- Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression. (2012) — 179 citations
- SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells (2015) — 50 citations
- RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation. (2012) — 196 citations
- The histone methyltransferase SMYD2 methylates PARP1 and promotes poly(ADP-ribosyl)ation activity in cancer cells. (2014) — 104 citations
- PRMT1 promotes mitosis of cancer cells through arginine methylation of INCENP (2015) — 36 citations
- Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN (2015) — 92 citations
- Equimolar Production of Amyloid β-Protein and Amyloid Precursor Protein Intracellular Domain from β-Carboxyl-terminal Fragment by γ-Secretase* (2006) — 145 citations
- Critical roles of SMYD2-mediated β-catenin methylation for nuclear translocation and activation of Wnt signaling (2017) — 43 citations
- Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production (2002) — 937 citations
- WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck (2020) — 15 citations
- Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization (2017) — 31 citations
- SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1 (2016) — 51 citations
- Structural basis for amino acid export by DMT superfamily transporter YddG (2016) — 71 citations
- PRMT6 increases cytoplasmic localization of p21CDKN1A in cancer cells through arginine methylation and makes more resistant to cytotoxic agents (2015) — 50 citations
- Dodeca-CLE Peptides as Suppressors of Plant Stem Cell Differentiation (2006) — 621 citations
- Plant cells recognize chitin fragments for defense signaling through a plasma membrane receptor. (2006) — 1,131 citations
- alpha-Synuclein is phosphorylated in synucleinopathy lesions. (2002) — 941 citations
- α-Synuclein is phosphorylated in synucleinopathy lesions (2002) — 1,871 citations